BioSpace News Archive

Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that members of management will present at three upcoming investor conferences in August: 2020 Wedbush PacGrow Healthcare Virtual Conference Date: Tuesday, August 11, 2020 Time: 11:30 a.m. ET BTIG Virtual Bio

Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the appointment of Fang Ni, Pharm.D., as Chief Business Officer. “Fang’s proven track record in business development and corporate strategy, including his work as Black Diamond’s interim Chief Business Officer, gives us confidence that he has

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on our Probody® therapeutic technology platform, announced today that Sean McCarthy, D.Phil., president, chief executive officer and chairman, will participate in the 2020 Wedbush PacGrow Virtual Healthcare Conference. Dr. McCarthy will present a Corporate

BOULDER, Colo., Aug. 04, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S. Marshall, Ph.D., President and Chief Executive Officer of miRagen, will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 12, 2020 at 1:10 p.m. ET. A live webcast of the event will be available on the investors page of the m

Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced the completion of the planned cohorts in a randomized, double-blind, placebo-controlled, two-part Phase 1 clinical trial to evaluate sing

Liver plays a key role in undertaking a number of critical body functions including the production of bile for digestion of food, synthesis of blood clotting compounds, detoxification, and the storage of essential sugars in the form of glycogen.

TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced that it has submitted an indications filing to the FDA to expand General Surgery usage of the Senhance Surgical System.

The global market for high-resolution melting analysis is gaining momentum on account of the advancements in molecular biology.

Replimune Group, Inc. a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, announced that members from the Replimune management team will present and host investor meetings at the following two conferences.